Newron Reports Top-Line Results From Its STARS Study Evaluating Sarizotan in Patients With Rett Syndrome
Pivotal trial did not meet primary or secondary efficacy variables Newron will prioritize its Phase III development program of Evenamide…
Pharmaceuticals, Biotechnology and Life Sciences
Pivotal trial did not meet primary or secondary efficacy variables Newron will prioritize its Phase III development program of Evenamide…
First therapeutic to receive PRIME designation in pulmonary arterial hypertension since the EMA established the program in 2016 PRIME designation…
PROLEUKIN® (aldesleukin) – the first and only approved recombinant IL-2 BURTON UPON TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today provided an update on its pilot clinical…
TAZVERIK™ Successfully Launched for First Approved Indication; PDUFA Date of June 18, 2020 for sNDA for Follicular Lymphoma Indication Business…
– Beyond expectations, a single injection of DNA in mice induced antibodies that block the infection of cultured human cells…
LONDON–(BUSINESS WIRE)–#EAACI2019–Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application…
LYON, France & STRASBOURG, France–(BUSINESS WIRE)–$TNG–Regulatory News: Vaxxel SAS, a French start-up, developing vaccines against respiratory viral infections, announces the…
PARIS & MONTREAL–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercialization…
AbCellera’s world-leading drug discovery technology identifies antibodies for potential use in drugs to treat and prevent COVID-19 got cash support from Canadian Government of $175.6 million.